PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40747233,Systemic treatment of liver cancer: Current status and future perspectives.,2025,"Chun-Bo Li, Yu-Ting Ning, Nai-Ying Shen, Ben Wang, Han Xiao, Gang Luo","Department of General Surgery, No. 215 Hospital of Shaanxi Nuclear Industry, Xianyang 712000, Shaanxi Province, China., Department of General Surgery, Xi'an Medical College, Xi'an 710000, Shaanxi Province, China., Department of General Surgery, No. 215 Hospital of Shaanxi Nuclear Industry, Xianyang 712000, Shaanxi Province, China., Department of General Surgery, No. 215 Hospital of Shaanxi Nuclear Industry, Xianyang 712000, Shaanxi Province, China., Department of Hepato-Biliary-Pancreatic Surgery, The First Hospital of Jiujiang City, Jiujiang 332000, Jiangxi Province, China., Department of Hepato-Biliary-Pancreatic Surgery, The First Hospital of Jiujiang City, Jiujiang 332000, Jiangxi Province, China.",N/A
40747229,Molecular tumor boards in pancreatic cancer with liver metastasis: A case report.,2025,"Yan Yan, Jing Tang","Department of Clinical Pharmacy, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing 102218, China., Department of Clinical Pharmacy, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing 102218, China. tj_0208@163.com.",N/A
40747115,Self-propelled gas nanomotor-integrated microneedles for melanoma therapy: Dual-action in situ eradication and metastatic suppression.,2025,"Chungchi Lee, Shanghui Huang, Huiling Liu, Xinyue He, Yifan Hao, Lizhi Zeng, Yuhan Li, Zijin Lv, Yiyang Xu, Rui Guo","Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Key Laboratory of Regenerative Medicine of Ministry of Education, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China., Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Key Laboratory of Regenerative Medicine of Ministry of Education, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China., Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Key Laboratory of Regenerative Medicine of Ministry of Education, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China., Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Key Laboratory of Regenerative Medicine of Ministry of Education, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China., Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Key Laboratory of Regenerative Medicine of Ministry of Education, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China., Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Key Laboratory of Regenerative Medicine of Ministry of Education, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China., Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Key Laboratory of Regenerative Medicine of Ministry of Education, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China., Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Key Laboratory of Regenerative Medicine of Ministry of Education, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China., Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Key Laboratory of Regenerative Medicine of Ministry of Education, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China., Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Key Laboratory of Regenerative Medicine of Ministry of Education, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrier Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China.",N/A
40746964,LPA,2024,"Jingyue Yan, Diana D Kang, Shi Du, Yonger Xue, Yizhou Dong","Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA., Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA., Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA., Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA., Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.",N/A
40746887,"Tumor Vaccines for Malignant Melanoma: Progress, Challenges, and Future Directions.",2025,"Yibo He, Judong Song","Department of Clinical Lab, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310060, China., Department of Pharmacy, The First People's Hospital of Lin'an District, Hangzhou, Lin'an People's Hospital Affiliated to Hangzhou Medical College, Hangzhou, 311399, China.",N/A
40746669,"Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted Agents.",2025,"Russell W Madison, Zoe June Assaf, Alexander Fine, Yi Cao, Ole Gjoerup, Yanmei Huang, Dexter X Jin, Jason Hughes, Amanda Young, David Fabrizio, David Shames, Sophia Maund, Alexia Exarchos, Lincoln W Pasquina, Katja Schulze","Foundation Medicine, Inc., Cambridge, Massachusetts., Genentech, Inc., South San Francisco, California., Foundation Medicine, Inc., Cambridge, Massachusetts., Genentech, Inc., South San Francisco, California., Foundation Medicine, Inc., Cambridge, Massachusetts., Foundation Medicine, Inc., Cambridge, Massachusetts., Foundation Medicine, Inc., Cambridge, Massachusetts., Foundation Medicine, Inc., Cambridge, Massachusetts., Foundation Medicine, Inc., Cambridge, Massachusetts., Foundation Medicine, Inc., Cambridge, Massachusetts., Genentech, Inc., South San Francisco, California., Genentech, Inc., South San Francisco, California., Genentech, Inc., South San Francisco, California., Foundation Medicine, Inc., Cambridge, Massachusetts., Genentech, Inc., South San Francisco, California.",N/A
40746212,Novel Carrier-Free Nanomedicine for Regulating Macrophage Phenotype to Amplify Anti-Tumor Photoimmunotherapy.,2025,"Jingfeng Xiang, Daoming Zhu","Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China., Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.",N/A
40746171,Real-world safety of HPV vaccines over 18 y: A comprehensive analysis of U.S. VAERS reports.,2025,"Yonglong Su, Yirong Huang, Jinbao Wei, Xinjin Wang, Yanyan Zhou, Xiaohong Wu, Honghong Fu","Xiamen Haicang Hospital, Xiamen, Fujian Province, China., Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China., Xiamen Haicang Hospital, Xiamen, Fujian Province, China., Fujian Institute for Food and Drug Quality Control, Fuzhou, Fujian Province, China., Xiamen Haicang Hospital, Xiamen, Fujian Province, China., Xiamen Haicang Hospital, Xiamen, Fujian Province, China., Fujian Institute for Food and Drug Quality Control, Fuzhou, Fujian Province, China.",N/A
40744663,Universal Fab-Fc masked cytokine prodrug platform: Î±PD-L1/IL-15 prodrug activates CD44,2025,"Luyao Song, Gen Qi, Wenqiang Shi, Qiongya Zeng, Ying Qin, Zejian Wang, Wei Li, Zilan Song, Ao Zhang, Huili Lu","National Key Laboratory of Innovative Immunotherapy; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China., National Key Laboratory of Innovative Immunotherapy; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China., National Key Laboratory of Innovative Immunotherapy; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China., National Key Laboratory of Innovative Immunotherapy; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China., National Key Laboratory of Innovative Immunotherapy; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China., National Key Laboratory of Innovative Immunotherapy; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China., National Key Laboratory of Innovative Immunotherapy; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China., National Key Laboratory of Innovative Immunotherapy; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China., National Key Laboratory of Innovative Immunotherapy; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China roadeer@sjtu.edu.cn ao6919zhang@sjtu.edu.cn., National Key Laboratory of Innovative Immunotherapy; Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China roadeer@sjtu.edu.cn ao6919zhang@sjtu.edu.cn.",N/A
40744660,MIAT promotes tumor-infiltrating CD8,2025,Lan-Yu Jing,"Breast Department, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Academy of Medical Sciences, Guangzhou, China.",N/A
40744025,Who is responsible for cancer survivorship care?,2025,Alice Indini,"Melanoma Unit, Department of Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; Immunotherapy and Innovative Therapeutics Unit, Department of Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. Electronic address: alice.indini@istitutotumori.mi.it.",maryam.lustberg@yale.edu.
40743785,"The evolving role of multimodal imaging, artificial intelligence and radiomics in the radiologic assessment of immune related adverse events.",2025,Dorine DeJong,"RefleXion Medical, Inc., Hayward, CA 94545, USA.",N/A
40743771,MAGE-A3 as a target for cancer immunotherapy: A systematic review of clinical and preclinical evidence.,2025,"Gaurang Telang, Smriti Mishra, Samruddhi Kulkarni, Rajshri Singh","Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: gaurangtelang98@gmail.com., Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: smritimishra44@gmail.com., Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: samkul1823@gmail.com., Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: rsingh1@mum.amity.edu.",drjoshisr@gmail.com.
40743763,Clinical Outcomes and Quality of Life in Cancer Patients Undergoing Immunotherapy: A Scoping Review.,2025,"Kiran A S Mahadev, Yeannie Hui-Yeng Yap","Division of Applied Biomedical Sciences and Biotechnology, School of Health Sciences, IMU University, Bukit Jalil, 57000 Kuala Lumpur, Malaysia., Division of Applied Biomedical Sciences and Biotechnology, School of Health Sciences, IMU University, 57000 Kuala Lumpur, Malaysia; Department of Oral Biology and Biomedical Sciences, Faculty of Dentistry, MAHSA University, 42610 Jenjarom, Selangor, Malaysia.",N/A
40743762,Supercharged NK Cells as a Promising Therapeutic Strategy to Target and Eliminate Aggressive DIPG Tumors in Pediatric Patients.,2025,"Anahid Jewett, Kawaljit Kaur, Naira Gharamanians","Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, University of California School of Dentistry, 10833 Le Conte Ave, 90095 Los Angeles, CA, USA; The Jonsson Comprehensive Cancer Center, UCLA School of Dentistry and Medicine, Los Angeles, CA, USA., Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, University of California School of Dentistry, 10833 Le Conte Ave, 90095 Los Angeles, CA, USA., Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, University of California School of Dentistry, Los Angeles, CA 90095, USA.",N/A
40743697,DNA repair at the crossroads of tumor immunogenicity and cancer therapy: Harnessing innate and adaptive immune pathways for improved therapeutic outcomes.,2025,"Zhanfeng Liang, Yangrui Xu, Chuan-Yuan Li","Institute for Molecular and Cellular Therapeutics, Chinese Institutes for Medical Research, Beijing, China., Institute for Molecular and Cellular Therapeutics, Chinese Institutes for Medical Research, Beijing, China., Institute for Molecular and Cellular Therapeutics, Chinese Institutes for Medical Research, Beijing, China; School of Basic Medical Sciences, Capital Medical University, Beijing, China. Electronic address: chuanli@cimrbj.ac.cn.",N/A
40743617,Microneedle-Mediated Delivery for Targeted Cancer Therapy: A Comprehensive Review.,2025,"S M Simi, R Pruthvi, K S Nagashree, Bhavya Malgur Vishweshwaraiah, Riyaz Ali M Osmani","Department of Pharmacology, JSS College of Pharmacy, Mysuru 570015, India., Department of Pharmacology, JSS College of Pharmacy, Mysuru 570015, India., JSS College of Pharmacy, Mysuru, JSS Academy of Higher Education & Research, Mysuru, 570 015, Karnataka, India., Department of Pharmaceutics, Sambrama College of Pharmacy, Mandya 571401, India., Department of Pharmaceutics, JSS College of Pharmacy, Mysuru 570015, India.",N/A
40743615,"Advancements in Skin Cancer Prevention and Treatment: Harnessing Technology, Natural Therapies, and Emerging Diagnostic Approaches.",2025,"Roshan Kumar Gupta, Lensi Parvadiya, Kiran Dudhat","School of Pharmacy, RK University, Kasturbadham, Rajkot, Gujarat 360020, India., School of Pharmacy, RK University, Kasturbadham, Rajkot, Gujarat 360020, India., School of Pharmacy, RK University, Kasturbadham, Rajkot, Gujarat-360020, India.",N/A
40743488,Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction.,2025,Emilio Ciusani,"Laboratory of Neurological Biochemistry and Neuropharmacology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.",N/A
40743444,NO-Driven Self-Propelled Nanomotors Augment Chemo-Immunotherapy and Transcatheter Arterial Embolization.,2025,"Zhaoyu Ma, Lei Chen, Yue Xi, Kai Zhang, Yang Liu, Wenbin Zhong, Yiming Liu, Chuansheng Zheng, Yanli Zhao","School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore., Hubei Province Key Laboratory of Molecular Imaging, Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore., School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore., School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore., School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore., Hubei Province Key Laboratory of Molecular Imaging, Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Hubei Province Key Laboratory of Molecular Imaging, Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore.",N/A
40742602,Emerging Role of Pathologic Response in Head and Neck Squamous Cell Carcinoma Immunotherapy.,2025,Trisha M Wise-Draper,"Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio.",N/A
40742520,Genetically Modified Lactic Acid Bacteria: a Promising Mucosal Delivery Vector for Vaccines.,2025,"Ariful Islam, Valentina Yurina","Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh., Department of Pharmacy, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia.",N/A
40742385,PI3K/Akt signaling pathway regulates CD155 expression involved in resistance to cancer immunotherapy.,2025,Tatsuya Nishi,"Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.",N/A
40742310,Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes Lymphoma Cells to Ferroptosis and CAR T-cell Immunotherapy.,2025,J J David Ho,"Kestrel Therapeutics, Allston, MA, United States.",N/A
40742002,Transcriptome profiling of prostatic tumours from ENACT trial patients with or without enzalutamide.,2025,"Elai Davicioni, Xin Zhao, Dina Elsouda, Yang Liu, James A Proudfoot, Gaston Kuperman, David Russell, Kenneth K Iwata","Veracyte, Inc., San Francisco, CA, USA., Veracyte, Inc., San Francisco, CA, USA., Astellas Pharma Inc., Northbrook, IL, USA., Veracyte, Inc., San Francisco, CA, USA., Veracyte, Inc., San Francisco, CA, USA., Astellas Pharma Inc., Northbrook, IL, USA., Pfizer Inc., New York, NY, USA., Astellas Pharma Inc., Northbrook, IL, USA.",N/A
40741879,Artificial Intelligence and the Evolving Landscape of Immunopeptidomics.,2025,"Thanh Hoa Vo, Edel McNeela, Orla O'Donovan, Sweta Rani","Department of Science, Pharmaceutical and Molecular Biotechnology Research Center (PMBRC), South East Technological University, Waterford, Ireland., Department of Science, Pharmaceutical and Molecular Biotechnology Research Center (PMBRC), South East Technological University, Waterford, Ireland., Department of Science, Pharmaceutical and Molecular Biotechnology Research Center (PMBRC), South East Technological University, Waterford, Ireland., Department of Science, Pharmaceutical and Molecular Biotechnology Research Center (PMBRC), South East Technological University, Waterford, Ireland.",N/A
40741426,Immunotherapy-related cystitis induced by nivolumab: A case report and review of the literature.,2025,Lianqing Lou,"Department of Critical Care Medicine, Yiwu Central Hospital, Zhejiang Province, China.",N/A
40741411,Bioinformatics-based analysis of the relationship between STC1 expression and immune infiltration in gastric cancer.,2025,"Xiaoli Ma, Yaoqi Li","The Department of Rehabilitation, Gansu Provincial Maternity and Child-Care Hospital (Gansu Provincial Center Hospital), Lanzhou, China., Department of Surgical Oncology, Gansu Provincial Hospital, Lanzhou, China.",N/A
40740483,PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment.,2025,"Zhenwang Zhang, Milad Ashrafizadeh","Hubei Key Laboratory of Diabetes and Angiopathy School of Pharmacy Xianning Medical College Hubei University of Science and Technology Xianning Hubei Province China., Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan Shandong China.",N/A
40740361,"Knowledge, attitude, and perception of the parents toward HPV vaccine administration to their children in Saudi Arabia: a cross-sectional study.",2025,"Abubaker S Bakhashab, Saja A Aljilani, Noura M Alkinaidri, Abdulaziz A Felimban, Moheealdeen H Habbal, Nawaf A Bashah, Ragia H Ghoneim, Diena Almasri, Masaad Saeed Almutairi, Abrar K Thabit","Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia., Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia., Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia., Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia., Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia., Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia., Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia., Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia., Department of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim, Saudi Arabia., Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.",N/A
40740240,Comprehensive Mendelian randomization and colocalization analysis of plasma proteomics to identify new therapeutic targets for bladder cancer.,2025,"Lingxiang Wen, Junxian Zhao, Yuanzhi Fu","Kunming Medical University, Kunming City, Yunnan Province, China., Department of Urology, 920th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Kunming, Yunnan Province, China., Kunming University of Science and Technology, Kunming City, Yunnan Province, China.",N/A
40740117,Tumor-responsive nanomedicines for cancer therapy: design principles and therapeutic advances.,2025,"Yan Liu, Yinan Wang, Ahequeli Gemingnuer, Hailing Wang, Xin Meng","School of Pharmacy, Heilongjiang University of Chinese Medicine, NO.24 Heping Road, Harbin 150040, People's Republic of China., School of Pharmacy, Heilongjiang University of Chinese Medicine, NO.24 Heping Road, Harbin 150040, People's Republic of China., School of Pharmacy, Heilongjiang University of Chinese Medicine, NO.24 Heping Road, Harbin 150040, People's Republic of China., School of Pharmacy, Heilongjiang University of Chinese Medicine, NO.24 Heping Road, Harbin 150040, People's Republic of China., School of Pharmacy, Heilongjiang University of Chinese Medicine, NO.24 Heping Road, Harbin 150040, People's Republic of China.",N/A
40739998,Cancer and fertility management: FIGO best practice advice.,2025,"Jacqueline P W Chung, Liona C Poon","Department of Obstetrics and Gynaecology, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, SAR, China., Department of Obstetrics and Gynaecology, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, SAR, China.",N/A
40739792,Role of monocarboxylate transporters in cancer immunology and their therapeutic potential.,2025,"Ferdos Faghihkhorasani, Al-Hasnawi Rasool Riyadh Abdulwahid, Amir Reza Aref","Medical Campus, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China., Medical Campus, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China., Department of Vitro Vision, DeepkinetiX, Inc., Boston, Massachusetts, USA.",N/A
